Format

Send to

Choose Destination
Eur Urol. 2017 Mar;71(3):415-416. doi: 10.1016/j.eururo.2016.10.034. Epub 2016 Nov 2.

Linking Gene Mutations to Clinical Outcomes and Response to Therapy in Clear-cell Renal Cell Carcinoma: Ready for Prime Time?

Author information

1
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
2
Department of Medical Oncology, Pitie-Salpêtrière Hospital, University Pierre and Marie Curie, Paris, France.
3
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ntannir@mdanderson.org.
PMID:
27816301
DOI:
10.1016/j.eururo.2016.10.034
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center